Obesity has become a worldwide epidemic, and its prevalence has been projected to grow
by 40% in the next decade. This increasing prevalence has implications for the risk of …

Chronic kidney disease (CKD) affects> 10% of the adult population. Each year,
approximately 120,000 Americans develop end-stage kidney disease and initiate dialysis …

Protein energy wasting (PEW) is common in patients with chronic kidney disease (CKD) and
is associated with adverse clinical outcomes, especially in individuals receiving …

The recent research findings concerning syndromes of muscle wasting, malnutrition, and
inflammation in individuals with chronic kidney disease (CKD) or acute kidney injury (AKI) …

Background Weight loss and homeostatic disturbances of both energy and protein balances
are characteristics of several illnesses including cancer, heart failure, and chronic kidney …

In the general population, obesity is associated with increased cardiovascular risk and
decreased survival. In patients with end-stage renal disease (ESRD), however, an “obesity …

The term uraemic myopathy has been used loosely to describe the skeletal muscle
abnormalities in uraemic patients. However, it does not fully explain the observed …

BACKGROUND: In patients with chronic heart failure (CHF), previous studies have reported
reduced mortality rates in patients with increased body mass index (BMI). The potentially …

Older people constitute an increasingly greater proportion of patients with advanced CKD,
including those patients undergoing maintenance dialysis treatment. Frailty is a biologic …

Obesity is associated with higher mortality in the general population, but this association is
reversed in patients on dialysis. The nature of the relationship of obesity with adverse …